Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Magnetic nanoparticles influence the biological function of mesenchymal stem cells. | Sci Rep | 2025 | 40739120 | PubTator, text mining | PubMed |
| Deciphering gene-smoking interactions in age-related macular degeneration through cross-biobank genomic integration. | Tob Induc Dis | 2025 | 40735363 | PubTator, text mining | PubMed |
| Proactive identification of rare diseases: lessons from hereditary angioedema diagnosis using electronic medical records. | Orphanet J Rare Dis | 2025 | 40722186 | PubTator, text mining | PubMed |
| Novel Insights into Schizophrenia Treatment: Comprehensive Analysis Unveiling FGFR1 as a Promising Druggable Gene. | Mol Neurobiol | 2025 | 40685484 | PubTator, text mining | PubMed |
| The determinants of angioedema attacks related to dental and gingival procedures in hereditary angioedema patients. | BMC Oral Health | 2025 | 40604794 | PubTator, text mining | PubMed |
| Comparative study of flow rate- and material-dependent human plasma protein adsorption on oxygenator membranes and heat exchanger materials. | Front Cardiovasc Med | 2025 | 40599623 | PubTator, text mining | PubMed |
| Can interferon-inducible gene expression guide treatment? A prospective study in QuantiFERON-positive uveitis with undetermined cause. | Taiwan J Ophthalmol | 2025 | 40584196 | PubTator, text mining | PubMed |
| [Biomarkers selection and prediction of disease progression in tuberculosis patients based on transcriptome expression data]. | Zhonghua Jie He He Hu Xi Za Zhi | 2025 | 40582977 | PubTator, text mining | PubMed |
| Relationship between early and mid-lateal phase progesterone levels and the DNA methylation of WOI-related genes in cervical secretions in fresh and frozen IVF cycles. | F S Sci | 2025 | 40578764 | PubTator, text mining | PubMed |
| An Atypical Case of Angioedema With Normal C1-Inhibitor Responding to Both C1-Inhibitor Concentrate and Omalizumab. | J Dermatol | 2025 | 40576280 | PubTator, text mining | PubMed |
| C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle-aged patients. | Clin Transl Allergy | 2025 | 40551525 | PubTator, text mining | PubMed |
| The 'autoimmunome' of centenarians. | J Transl Autoimmun | 2025 | 40546301 | PubTator, text mining | PubMed |
| MicroRNA-29a-5p attenuates hemorrhagic transformation and improves outcomes after mechanical reperfusion for acute ischemic stroke. | Noncoding RNA Res | 2025 | 40529227 | PubTator, text mining | PubMed |
| Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future. | World Allergy Organ J | 2025 | 40487881 | PubTator, text mining | PubMed |
| Unveiling the levels and significance of different serpin family proteins in aqueous humor dynamics. | BMC Ophthalmol | 2025 | 40389884 | PubTator, text mining | PubMed |
| Angioedema without urticaria: Diagnosis and management. | Allergy Asthma Proc | 2025 | 40380367 | PubTator, text mining | PubMed |
| Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. | J Immunother Cancer | 2025 | 40379271 | PubTator, text mining | PubMed |
| New Gene Targets for Diagnosis and Therapy of Diabetic Retinopathy. | Eurasian J Med | 2025 | 40377287 | PubTator, text mining | PubMed |
| Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant. | Sci Rep | 2025 | 40374692 | PubTator, text mining | PubMed |
| Disrupting lipid homeostasis with CAV2 in OSCC triggers apoptosis, lipolysis, and mitochondrial dysfunction by transcriptional repression of PPARγ. | Cell Biosci | 2025 | 40369665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=9